noun: (pharmacology) A genetically engineered monoclonal antibody (trademark Simponi) that inhibits the activity of tumor necrosis factor and is administered by subcutaneous injection to treat rheumatoid arthritis, psoriatic arthritis, ankylosing spondylitis, and ulcerative colitis.
